Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
- PMID: 22137551
- DOI: 10.5588/ijtld.11.0178
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
Abstract
Setting: Recently, Mycobacterium tuberculosis isolates have been described that test phenotypically susceptible to rifampicin (RMP) yet harbour genotypic rpoB mutations.
Objective: 1) To investigate the impact of such mutations on clinical outcomes among RMP-susceptible isolates, and 2) to determine the prevalence of rpoB mutations among isoniazid (INH) monoresistant isolates at our laboratory and to describe the association between the presence of these mutations and clinical outcomes.
Methods: M. tuberculosis isolates were screened for mutations in the rpoB gene using the Cepheid Gene-Xpert® MTB/RIF assay. Clinical correlation was made by reviewing patient case notes.
Results: Isolates from 94 patients were found to have INH-resistant, RMP-susceptible profiles. Clinical information was available for 52 patients, including three whose isolates had rpoB mutations. All three of these patients had treatment failures, compared to two of 49 patients whose isolates did not have rpoB mutations (P = 0.0005).
Discussion: We demonstrate a significant association between the presence of rpoB gene mutations that are not detected at the current RMP critical concentration and treatment failure. We suggest that a review of the current RMP critical concentration is warranted to ensure that RMP is not used inappropriately for the treatment of phenotypically occult multidrug-resistant tuberculosis.
Comment in
-
Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs.Int J Tuberc Lung Dis. 2012 May;16(5):706-7. doi: 10.5588/ijtld.11.0850. Int J Tuberc Lung Dis. 2012. PMID: 22507940 No abstract available.
Similar articles
-
Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.J Antimicrob Chemother. 2013 Dec;68(12):2915-20. doi: 10.1093/jac/dkt284. Epub 2013 Jul 9. J Antimicrob Chemother. 2013. PMID: 23838950
-
Drug-resistant tuberculous meningitis.Expert Rev Anti Infect Ther. 2013 Jun;11(6):605-21. doi: 10.1586/eri.13.39. Expert Rev Anti Infect Ther. 2013. PMID: 23750732 Review.
-
Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.Int J Tuberc Lung Dis. 2011 Jan;15(1):110-5. Int J Tuberc Lung Dis. 2011. PMID: 21276306
-
A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis.Clin Microbiol Infect. 2010 Jun;16(6):607-12. doi: 10.1111/j.1469-0691.2009.02932.x. Epub 2009 Aug 7. Clin Microbiol Infect. 2010. PMID: 19673965
-
Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.Thorax. 1998 Sep;53(9):793-7. doi: 10.1136/thx.53.9.793. Thorax. 1998. PMID: 10319064 Free PMC article. Review. No abstract available.
Cited by
-
Rifampin Mono-Resistant Tuberculosis in New York City, 2010-2021: A Retrospective Case Series.Open Forum Infect Dis. 2023 Nov 21;10(11):ofad534. doi: 10.1093/ofid/ofad534. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023554 Free PMC article.
-
Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy.Microbiol Spectr. 2024 Jan 11;12(1):e0163123. doi: 10.1128/spectrum.01631-23. Epub 2023 Nov 20. Microbiol Spectr. 2024. PMID: 37982632 Free PMC article.
-
Pyrazinamide resistance in rifampicin discordant tuberculosis.PLoS One. 2022 Sep 21;17(9):e0274688. doi: 10.1371/journal.pone.0274688. eCollection 2022. PLoS One. 2022. PMID: 36129921 Free PMC article.
-
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.PLoS One. 2022 Sep 13;17(9):e0274426. doi: 10.1371/journal.pone.0274426. eCollection 2022. PLoS One. 2022. PMID: 36099255 Free PMC article.
-
Minos: variant adjudication and joint genotyping of cohorts of bacterial genomes.Genome Biol. 2022 Jul 5;23(1):147. doi: 10.1186/s13059-022-02714-x. Genome Biol. 2022. PMID: 35791022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical